MapLight Therapeutics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Mailing Address
800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Phone
650-839-4360
Fiscal Year End
1231
EIN
832163243
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 20, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 9, 2026 | View on SEC |
IPO Filings
S-1
September 19, 2025
- Portfolio of brain-targeted drugs addressing major neurological conditions (autism, Parkinson’s, schizophrenia, Alzheimer’s psychosis) with a late-stage candidate (ML-007C-MA).
- Innovative 'brain circuit repair' approach for precision treatment, potentially offering fewer side effects than existing therapies.
Annual Reports
10-K
March 26, 2026
- Proprietary AI-driven 'MapLight Circuit-Based Drug Discovery' platform.
- Lead drug candidate ML-007C-MA targeting schizophrenia and Alzheimer’s-related psychosis.
Insider Trading
STRONG SELL
3 insiders
17 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.